---
title: "KANZHUN LIMITED - American Depository Shares Stock 12‑Month Price Target Raised to $20.78, Implies 48% Upside"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/292011613.md"
description: "Analysts have raised the average 12-month price target for KANZHUN LIMITED ADS to $20.78, up from $20.42, implying a 48% upside based on the July 7 closing price. The consensus rating remains 'Buy' across 23 covering analysts, with no holds or sells."
datetime: "2026-07-08T04:20:06.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/292011613.md)
  - [en](https://longbridge.com/en/news/292011613.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/292011613.md)
generator: "portal-rs"
---

# KANZHUN LIMITED - American Depository Shares Stock 12‑Month Price Target Raised to $20.78, Implies 48% Upside

-   According to estimates from 19 analysts, KANZHUN LIMITED - American Depository Shares stock's average price target has risen from $20.42 to $20.78, with forecasts ranging from $15.69 to $25.98 per share
-   Based on the Jul. 7 closing price, the updated target implies approximately 48% potential upside
-   Consensus rating remains at “Buy” across 23 covering analysts, with 23 Buys, 0 Holds and 0 Sells

Explore more price target data and ratings for KANZHUN LIMITED - American Depository Shares on the , and track all previous and future analyst recommendations for KANZHUN LIMITED - American Depository Shares in the dedicated News Flow.

**Disclaimer**

Select reference data provided by FactSet. Copyright © 2026 FactSet Research Systems Inc. This information is not a recommendation for what you should do personally and does not constitute investment advice.

### Related Stocks

- [02076.HK](https://longbridge.com/en/quote/02076.HK.md)
- [BZ.US](https://longbridge.com/en/quote/BZ.US.md)
- [FDS.US](https://longbridge.com/en/quote/FDS.US.md)

## Related News & Research

- [Kanzhun Eyes Brazil, Argentina And Vietnam For Growth](https://longbridge.com/en/news/297362638.md)
- [Online recruitment platform Kanzhun Q2 revenue rises 14% on enterprise customer growth](https://longbridge.com/en/news/296915232.md)
- [20/20 Biolabs outlines FDA engagement, Medicare reimbursement pathway and commercial gains](https://longbridge.com/en/news/297829170.md)
- [Where Will Paramount Skydance (NASDAQ:PSKY) Move To?](https://longbridge.com/en/news/298231998.md)
- [Netflix subscription rises above £20 a month for first time](https://longbridge.com/en/news/298063875.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**